Abstract:Oleoylethanolamide (OEA), an endocannabinoid-like molecule, was revealed to modulate lipid metabolism through a peroxisome proliferator-activated receptor-α (PPAR-α) mediated mechanism. In present study, we further investigated the activities and mechanisms of OEA in ameliorating hepatic fibrosis in Sv/129 mice induced by a methionine choline-deficient (MCD) diet or thioacetamide (TAA) treatment. Liver fibrosis development was assessed by Hematoxylin-eosin and Sirius red staining. Treatment with OEA (5 mg/kg/day, intraperitoneal injection, i.p.) significantly attenuated the progress of liver fibrosis in both two experimental animal models by blocking the activation of hepatic stellate cells (HSCs). Gene expression analysis of hepatic tissues indicated that OEA inhibited the expression of α-smooth muscle action (α-SMA) and collagen matrix, fibrosis markers, and genes involved in inflammation and extracellular matrix remodeling. In vitro studies showed that OEA inhibited transforming growth factor β1-stimulated HSCs activation through suppressing Smad2/3 phosphorylation, α-SMA expression and myofibroblast transformation. These improvements could not be observed in PPAR-α knockout mice models with OEA administration, which suggested all the anti-fibrotic effects of OEA in vivo and in vitro were mediated by PPAR-α activation. Collectively, our results suggested that OEA exerted a pharmacological effect on modulating hepatic fibrosis development through the inhibition of HSCs activation in liver and therefore may be a potential therapeutic agent for liver fibrosis.

Synthesis of Oleoylethanolamide Analogues

Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL.

Effect of Propane-2-sulfonic Acid Octadec-9-enyl-amide on the Expression of Adhesion Molecules in Human Umbilical Vein Endothelial Cells.

Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy

Design and Synthesis of 3-(2-ethyl-4-{2-[2-(4-fluorophenyl)-5-methyloxazol-4-yl]ethoxy}phenyl)propanoic Acid: A Novel Triple-acting PPARα, -Γ, and -Δ Agonist

Design, synthesis, and biological evaluation of oxazolidone derivatives as highly potent N-acylethanolamine acid amidase (NAAA) inhibitors

Effect of Oleoylethanolamide on Diet-Induced Nonalcoholic Fatty Liver in Rats

Design and Synthesis of Novel Indole Ethylamine Derivatives as a Lipid Metabolism Regulator Targeting PPARα/CPT1 in AML12 Cells

Inhibition of TNFα-induced adhesion molecule expression by (Z)-(S)-9-octadecenamide, N-(2-hydroxyethyl,1-methyl).

The Hypolipidemic and Liver Protective Effect of Oleoylethanolamide in Hyperlipidemic Rats

Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N -acylethanolamine acid amidase (NAAA) inhibitors.

Design, Synthesis and CoMFA Studies of OEA Derivatives As FAAH Inhibitors

Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells

Design, synthesis and PPAR agonist activities of novel L-tyrosine derivatives containing phenoxyacetyl moiety

Synthesis and Identification of [1,2,4]thiadiazole Derivatives As A New Series of Potent and Orally Active Dual Agonists of Peroxisome Proliferator-Activated Receptors Alpha and Delta

Synthesis And Preliminary Evaluation Of Antidiabetic Activity Of 4-(1-Aryl-3-Aryl/Arylalkyl-3-Oxopropylamino)-N-(5-Methyl-3-Isoxazolyl)Be Nzene Sulfonamide

Design and Synthesis of Oleanolic Acid Rings A and C Lactone Derivatives

Structure-based Design, Synthesis, PPAR-γ Activation, and Molecular Docking of N-substituted Phthalimides

The Effect of Oleoylethanolamide on the Expression of Cytokines in Lipopolysaccharide Induced THP-1cells

Design and Synthesis of Potent N-Acylethanolamine-hydrolyzing Acid Amidase (NAAA) Inhibitor As Anti-Inflammatory Compounds

Synthesis and Evaluation of Novel Α-Heteroaryl-phenylpropanoic Acid Derivatives As PPARα/γ Dual Agonists